Changchun Hi-Tech (000661.SZ) subsidiary's application for marketing melatonin granules was accepted

Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) announced that the holding subsidiary of the company, Changchun Jinsai Pharmaceutical Co., Ltd. (“Jinsai Pharmaceutical”), received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's application for registration and marketing of domestically produced drugs for melatonin granules was accepted.

According to the announcement, melatonin granules are a child neuropsychiatric product developed by Jinsai Pharmaceutical. It belongs to class 4 chemicals. It can regulate neural activity in the suprachiasmatic nucleus by activating MT1 and MT2 receptors in the suprachiasmatic nucleus, showing the effect of inducing sleep. It is intended to improve sleep difficulties associated with neurological developmental disorders in childhood.